xIPOmeter
Alvotech
Alvotech is a biopharmaceutical company that specializes in the development and production of biosimilars. Their approach is highly integrated, encompassing everything from the initial development of cell lines to the final steps of product manufacturing. This allows for enhanced control and efficiency. The company's main goal is to make biologic medicines more accessible and affordable worldwide, thus improving patient care.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to Alvotech103
AlvotechIcelandic Biotech Alvotech Gets the Green Light : r/Spacstocks
r/Spacstocks - Icelandic Biotech Alvotech Gets the Green Light...
https://www.reddit.com/r/Spacstocks/comments/v78p54/icelandic_biotech_alvotech_gets_the_green_light/AlvotechAlvotech and Oaktree Acquisition Corp. II Announce Shareholder ...
r/Spacstocks - Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business...
https://www.reddit.com/r/Spacstocks/comments/v76zn5/alvotech_and_oaktree_acquisition_corp_ii_announce/AlvotechMy account My Account Notifications Log In QQQ ––% DIA ––% SPY ...
Teva and Alvotech will share profit from the commercialization of these biosimilars. In March 2021, Abbvie sued Alvotech for allegedly misappropriating ...
https://www.benzinga.com/secfilings/21/07/22207123/teva-pharmaceutical-industries-ltd-quarterly-report-form10AlvotechTeva Pharmaceutical Industries Ltd, TEVA:TLV summary - FT.com
Plus, unpacking the sustainable bond hype and Brad Pitt's affordable housing project hits trouble. January 31, 2022. European companies ...
https://markets.ft.com/data/equities/tearsheet/summary?s=TEVA:TLVAlvotechOACB | Oaktree Acquisition Corp. II Cl A SEC Filings | MarketWatch
OACB and Alvotech S.A. and their directors and executive officers may be deemed participants in the solicitation of proxies from OACB's shareholders with ...
https://www.marketwatch.com/investing/stock/oacb/financials/secfilings?docid=15824980
Show more (98)Investors5
AlvogenBaxter VenturesShinhan CapitalAthos CapitalAztiq Pharma